Rage Capital sources, diligences, and invests in frontier business models leveraging market-defining technologies.
Technology, we believe, is critical to closing the gap between our growing needs and diminishing resource supply. They foresee a society where not only is high quality of life widely available and abundant, but also where manufacturing is robust and environmentally sustainable. To improve the health of our world, it is our obligation to stimulate disruptive breakthroughs in the methods we produce and consume.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Jan 4, 2022
Remilk
|
Series B | $120M | Biotechnology | — |
Dec 7, 2021
The EVERY Company
|
Series C | $175M | Biotechnology | Yes |